A Blue Pill Is Stopping HIV, World-First Study Shows

New cases of HIV among gay and bisexual men fell by almost a third to the lowest on record, according to the world’s first study to measure the impact of Gilead Sciences Inc.’s Truvada pill on reducing the AIDS-causing virus in a large population. The blue, oval-shaped pill is a fixed-dose combination of the drugs tenofovir, disoproxil and emtricitabine

from Hindustan Times - health-fitness https://ift.tt/2RX8yYE